ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy

Bousquet, Jean; Pfaar, Oliver; Agache, Ioana; Bedbrook, Anna; Akdiş, Cezmi A.; Canonica, Giorgio Walter; Chivato, T.; Al‐Ahmad, Mona; Latiff, Amir Hamzah Abdul; Ansotegui, Ignacio J.; Bachert, Claus; Abdullah, Baharuddin; Bergmann, Karl‐Christian; Bindslev‐Jensen, Carsten; Bjermer, Leif; Bonini, Matteo; Bosnic‐Anticevich, Sinthia; Bossé, Isabelle; Brough, Helen A.; Brussino, Luisa; Calderón, Moisés A.; Caraballo, Luis; Cardona, Victòria; Carreiro‐Martins, Pedro; Casale, T.; Cecchi, Lorenzo; Sarabia, Alfonso M. Cepeda; Chkhartishvili, Ekaterine; Chu, Derek K.; Cirule, I.; Cruz, Ãlvaro A.; Czarlewski, Wienczyslawa; Giacco, Stefano Del; Demoly, Pascal; Devillier, Philippe; Dokic, D.; Durham, Stephen; Ebisawa, Motohiro; El‐Gamal, Yehia; Ėmužytė, Regina; Gamkrelidze, Amiran; Fauquert, J. L.; Fiocchi, Alessandro; Fokkens, Wytske J.; Fonseca, João; Fontaine, Jean François; Gawlik, Radosław; Gelincik, Aslı; Gemicioğlu, Bilun; Gereda, José E.; Wijk, Roy Gerth van; Gómez, René Maximiliano; Gotua, Maia; Grisle, I.; Guzmán, María Antonieta; Haahtela, Tari; Halken, Susanne; Heffler, Enrico; Hoffmann‐Sommergruber, Karin; Hossny, Elham; Hrubiško, M; Irani, Carla; Ivancevich, Juan Carlos; Ispayeva, Zhanat; Julge, Kaja; Kaidashev, Igor; Kalaycı, Ömer; Khaitov, Musa; Klimek, Ludger; Knol, Edward F.; Kowalski, Marek L.; Kraxner, Helga; Kull, Inger; Kuna, Piotr; Kvedarienė, Violeta; Kritikos, Vicky; Lauerma, Antti; Lau, Susanne; Laune, Daniel; Levin, Michael; Larenas‐Linnemann, Désiree; Carlsen, Karin C. Lødrup; Lombardi, Carlo; Lourenço, Olga; Mahboub, Bassam; Malling, H.‐J.; Manning, Patrick J.; Marshall, Gailen D.; Melén, Erik; Meltzer, Eli O.; Miculinic, N.; Milenković, Branislava; Moin, Mostafa; Montefort, Stephen; Morais‐Almeida, Mário; Mørtz, Charlotte G.; Mösges, Ralph; Mullol, Joaquim; Namazova-Baranova, Leyla; Neffen, Hugo; Nékám, K; Niedoszytko, Marek; Odemyr, Mikaëla; O’Hehir, Robyn E; Ollert, Markus; O’Mahony, Liam; Ohta, Ken; Okamoto, Yoshitaka; Okubo, Kimi; Pajno, Giovanni Battista; Palomares, Óscar; Palkonen, Susanna; Panzner, Petr; Papadopoulos, Nikolaos G.; Park, Hae‐Sim; Passalacqua, Giovanni; Patella, Vincenzo; Pawankar, Ruby; Pham‐Thi, N.; Plavec, Davor; Popov, Todor A.; Recto, Marysia T; Regateiro, Frederico S.; Riggioni, Carmen; Roberts, Graham; Rodriguez-Gonzales, Monica; Rosário, Nelson; Rottem, Menachem; Rouadi, Philip W.; Ryan, Dermot; Samoliński, Bolesław; Sánchez‐Borges, Mario; Serpa, Faradiba Sarquis; Sastre, Joaquı́n; Scadding, Glenis; Shamji, Mohamed H.; Schmid‐Grendelmeier, Peter; Schünemann, Holger J.; Sheikh, Aziz; Scichilone, Nicola; Sisul, Juan Carlos; Sofiev, Mikhail; Solé, Dírceu; Sooronbaev, Talant; Soto-Martinez, Manuel; Soto-Quirós, Manuel E.; Sova, Milan; Schwarze, Jürgen; Skypala, Isabel; Suppli‐Ulrik, Charlotte; Taborda-Barata, Luís; Todo‐Bom, Ana; Torres, Marı́a José; Valentín-Rostán, Marylin; Tomazic, Peter Valentin; Valero, Antonio; Toppila‐Salmi, Sanna; Tsiligianni, Ioanna; Untersmayr, Eva; Urrutia-Pereira, Marilyn; Valiulis, Arūnas; Valovirta, Erkka; Vandenplas, Olivier; Ventura, Maria Teresa; Vichyanond, Pakit; Wagenmann, Martin; Wallace, Dana; Walusiak‐Skorupa, Jolanta; Wang, De Yun; Waserman, Susan; Wong, Gary; Yorgancıoğlu, Arzu; Yusuf, Osman; Zernotti, Mario; Zhang, Luo; Zidarn, Mihaela; Zuberbier, Torsten; Jutel, Marek

doi:10.1002/clt2.12014

Cited by 34 publications

(12 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Allergen provocation tests might be necessary in cases of high suspicion and inconclusive allergy test results. 57,68 According to the ARIA-EAACI care pathway, both monosensitised (single dominant antigen) and polysensitised (multiple antigens) patients can benefit. 57,68 Patients who should be considered for AIT include the following:…”

Section: Allergen Immunotherapymentioning

confidence: 99%

See 1 more Smart Citation

Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group

Richards,

McDonald,

Gray

et al. 2023

South African Family Practice

View full text Add to dashboard Cite

Methods: This review is based on a comprehensive literature search and detailed discussions by the South African Allergic Rhinitis Working Group (SAARWG). Results:The working group provided up-to-date recommendations on the epidemiology, pathology, diagnosis and management of AR, appropriate to the South African setting. Conclusion:Allergic rhinitis causes significant, often unappreciated, morbidity. It is a complex disease related to an inflammatory response to environmental allergens. Therapy involves education, evaluation of allergen sensitisation, pharmacological treatment, allergen immunotherapy (AIT) and evaluation of the success of interventions. Regular use of saline; the important role of intranasal corticosteroids, including those combined with topical antihistamines and reduction in the use of systemic steroids are key. Practitioners should have a thorough knowledge of associated morbidities and the need for specialist referral.Contribution: This review summarises the latest developments in the diagnosis and management of AR such that it is a resource that allows easy access for family practitioners and specialists alike.

show abstract

Section: Allergen Immunotherapymentioning

confidence: 99%

“…57,68 According to the ARIA-EAACI care pathway, both monosensitised (single dominant antigen) and polysensitised (multiple antigens) patients can benefit. 57,68 Patients who should be considered for AIT include the following:…”

Section: Allergen Immunotherapymentioning

confidence: 99%

Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group

Richards,

McDonald,

Gray

et al. 2023

South African Family Practice

View full text Add to dashboard Cite

show abstract

“…There is increasing evidence for the effectiveness and secondary preventive effects of AIT based on prescription and coded data from patients covered by statutory health insurances [ 39 , 40 , 41 ]. An alternative to generate RWE data on the application of AIT outside clinical studies is to use hand-device applications (apps), which are being increasingly utilized by patients and may be helpful in the early stratification of patients for AIT and furthermore in therapy monitoring [ 42 , 43 ]. For example, based on the data set of the app “MASK-air” (Mobile Airways Sentinel Network [ 38 , 42 , 44 ]), a concept study recently demonstrated that AIT seems to reduce allergic symptoms in routine treatment and to increase the patients’ productivity at work [ 45 ].…”

Section: Chapter 3 Allergen Extracts Their Evaluation and Marketing A...mentioning

confidence: 99%

Guideline on allergen immunotherapy in IgE-mediated allergic diseases

Pfaar¹,

Ankermann²,

Augustin³

et al. 2022

ALS

Self Cite

View full text Add to dashboard Cite

show abstract

“…SCIT had been prescribed according to international guidelines [30,31]. The dosage and intervals of administration were established on the technical data sheet for the product (Supplementary file 1).…”

Section: Treatmentmentioning

confidence: 99%

Real-Life Effectiveness of Subcutaneous Immune Therapy with Carbamylated Monomeric Allergoids on Mite, Grass, and Pellitory Respiratory Allergy: A Retrospective Study

Gioacchino

Valle

Mangifesta

et al. 2022

JCM

View full text Add to dashboard Cite

Background: real-life studies are encouraged to evaluate the effectiveness and safety of allergen immunotherapy (AIT). In this context, a retrospective cohort study was conducted to assess the effectiveness and safety of carbamylated monomeric allergoid subcutaneous immunotherapy (MA-SCIT), along with patient satisfaction. Methods: a total of 291 patients with rhinoconjunctivitis with or without asthma with inhalant (house dust mite, grass, and pellitory) allergies were enrolled in this study. Perceived efficacy and perceived satisfaction with MA-SCIT, symptom score by VAS, ARIA classification of rhinitis, drug consumption, number of asthma worsening episodes, and asthma symptom control were evaluated by questionnaires before, after one year, at the end of treatment, and after one or two years of MA-SCIT. Results: the overall symptom score significantly decreased over the years of MA-SCIT, irrespective of specific sensitization (p < 0.01). There was a substantial amelioration of rhinitis severity, with a significant reduction (p < 0.01) in drug use. A significant reduction was observed in the asthma symptom VAS score and asthma-worsening episodes requiring systemic steroids. None of the patients reported any severe adverse reactions. Finally, 90% of the patients reported full satisfaction with the treatment. Conclusions: the study showed that AIT with carbamylated monomeric allergoids of grass, pellitory, and mites was effective and well tolerated by patients.

show abstract

ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy

Abstract: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Cited by 34 publications

References 0 publications

Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group

Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group

Guideline on allergen immunotherapy in IgE-mediated allergic diseases

Real-Life Effectiveness of Subcutaneous Immune Therapy with Carbamylated Monomeric Allergoids on Mite, Grass, and Pellitory Respiratory Allergy: A Retrospective Study

Contact Info

Product

Resources

About